The Status and Future of Integrative and Organ Systems Sciences October 20 – 21, 2002 Bethesda, MD Sponsored by:APS and ASPET Co-sponsors: Burroughs Wellcome.

Slides:

Advertisements

Similar presentations

Global Forum on Bioethics in Research – nearing 10 years of dialogue

Advertisements

Max Wilkinson NCRI Informatics Unit Promoting Data Standardisation Within the Cancer Community.

World of work How is science used in the world of work? Science in the world of work.

Research Design Service West Midlands RfPB Research Funding Application Workshop 28 th February 2014.

The Fellowships aim to: Educate scientists and engineers on the intricacies of federal policymaking Provide scientific and technical knowledge to support.

Briefing to the Commission to Review the Effectiveness of the National Energy Laboratories (CRENEL) Joseph McBrearty, Deputy Director for Field Operations.

Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.

“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.

Overview Division of Viral Products Office of Vaccines Research and Review Laboratory of Methods Development Site Visit January 9, 2003.

Sustaining AgrAbility Services During Difficult Times National AgrAbility Project Webinar September 23, 2013.

National Standards In Pathology Education Barbara Knollmann-Ritschel, M.D.

Office of Biotechnology Products

Future of Field Stations and Marine Labs: A strategic planning effort Supported by NSF, DBI to Ian C. Billick (PI), Brian Kloeppel, Ivar G. Babb,

An Overview of Mission-related Research Office of Blood Research and Review C.D. Atreya, Ph.D. Associate Director for Research OBRR, CBER BPAC, Dec

Graduate School Faculty of Medical Sciences Professor Barry Hirst Dean of Postgraduate Studies.

CBER Regulatory Laboratory Planning & Preparedness for SARS-related Biologics Products Kathryn M. Carbone MD Associate Director for Research, Acting, Center.

Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.

Center for Biologics Evaluation and Research FDA Overview Site Visit Carolyn A. Wilson, Ph.D. Associate Director for Research.

Office of Science Office of Biological and Environmental Research J Michael Kuperberg, Ph.D. Dan Stover, Ph.D. Terrestrial Ecosystem Science AmeriFlux.

Office of Cellular Tissue and Gene Therapies Celia M.Witten, Ph.D., M.D. Director, Office of Cellular, Tissue, and Gene Therapies Cellular, Tissue, and.

ENTERING THE SOUTH CAROLINA MARKET IN JANUARY 2014 A “CONSUMER OPERATED AND ORIENTED HEALTH PLAN” OR “CO-OP” 1.

The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.

The NIH Roadmap for Medical Research

School of Medicine Shared Resource Facilities The School of Medicine provides direct support and oversight to 21 SOM shared resource facilities. Their.

Panel: Assessing the Value of Biomedical Research from public and patient perspectives NIH SMRB Meeting: October 24, 2013 Elaine K. Gallin, Ph.D. QE Philanthropic.

NIGMS Training in Systems & Integrative Science Peter C. Preusch, Ph.D. Program Director Pharmacological Sciences Training Grant Program, NIGMS, NIH LSRO.

Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.

Cellular Products for Cardiac Diseases Dwaine Rieves, MD Center for Biologics Evaluation and Research FDA Perspective on:

©2009 RALPH SNYDERMAN 1 Personalized Health Care: The Foundation of Rational Health Reform Ralph Snyderman, MD Chancellor Emeritus, Duke University James.

The Federal German Funding Initiative Systems for Life - Systems Biology Structure – Coordination Jens Doutheil DECHEMA e.V. Frankfurt.

EuPA- EC Education Committee (EC) working plan.

Bernard A Fox, PhD Immediate Past President and Chair, Executive Council Society for Immunotherapy of Cancer (SITC) Defining the Critical Hurdles in Cancer.

INTERNATIONAL WORKSHOP ON THE EVALUATION OF PUBLICLY FUNDED RESEARCH Berlin, 26/27 September 2005.

The Human Genome Project: prospects for cardiology Claude L’Enfant MD Director, National Heart, Lung, and Blood Institute National Institutes of Health,

CAMARADES: Bringing evidence to translational medicine What could be going wrong? Randomisation and blinding.

Grantseeking Basics Did you pick up a handout packet from the table outside? PLEASE TURN OFF CELL PHONES! Welcome to the Foundation Center’s.

Translational Science in Cancer Health Disparities Research Peter Ujhazy, M.D., Ph.D. Program Director Translational Research Program Division of Cancer.

Dr. Siegfried Neumann-hg: WTEC_Demo_ ppt 1 A German Initiative on Systems Biology of Human Hepatocytes Systems of Life - Systems Biology Presentation.

Iván D Vélez MD PhD. Malaria ROL OF INVESTIGATORS  Politicians,  Health authorities  Pharmaceutical industry  Pipeline and deliver products for.

“Career Opportunities: Supply and Demand Factors Edward J. Zambraski, Ph.D. Department of Cell Biology & Neuroscience Rutgers University.

Presented by: Louise Desjardins, M.Sc., Ph.D. Executive Director December 3, 2014.

EXPLORATION COMMITTEE and Ad hoc BIOMEDICAL COMMITTEE October 16, 2008 NASA ADVISORY COUNCIL.

Structural Genomics Consortium releases 1,000th protein structure The Structural Genomics Consortium (SGC), an international public-private partnership.

The International Society For Cellular Therapy. Mission Statement ISCT is a global association driving the translation of scientific research to deliver.

Location, mission, & overview of the curriculum …… J. Peter Gergen (Director, Undergraduate Biology) UNDERGRADUATE BIOLOGY at STONY BROOK UNIVERSITY.

New Technologies: the Role of the Private Sector Biotech’s Perspectives on Vaccine Development Alliances Peter Young CEO, AlphaVax, Inc.

Clinical and Translational Science Institute / CTSI at the University of California, San Francisco UCSF DataShare Making Research Data Available to All.

Department of Biotechnology

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

Life Sciences Research Office, Inc. (LSRO) Michael Falk Executive Director.

Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.

What did you observe?. What is the main difference between Subject A and Subject B?

The Regulatory Science of Regenerative Medicine Celia M. Witten, Ph.D., M.D., Director Office of Cellular, Tissue and Gene Therapies Center for Biologics.

Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.

Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

Foundation Doctors’ Academic Meeting Kathryn Adcock Wellcome Trust March 2011.

Organizational Funding Portfolios and Beyond: Assessing the Full Research Landscape Panel Session 731 American Evaluation Association EVALUATION 2012 October.

Figure Molecular Biology of the Cell (© Garland Science 2008)

Figure 14-1 Molecular Biology of the Cell (© Garland Science 2008)

The National Science Foundation Independent Federal Agency Support for all fields of fundamental science and engineering.

GLI Executive Committee

IT Steering Committee 6/9/2018 BEGIN - CONTINGENCY.

Open Science in the US and opportunities for Neutron and Light Sources

Sponsored by: APS and ASPET Co-sponsors: Burroughs Wellcome Fund

Classification of proteins in PC-3 cell-released microvesicles by GOslim annotations. Classification of proteins in PC-3 cell-released microvesicles by.

Group Discussion 1: Structure & Organisation of a research society

Escaping the Valley of Death

Distribution of the phosphoproteins based on GO analysis, including biological process (Left) and cellular component (Right). Distribution of the phosphoproteins.

MD Tech Council – Doing Biz w/ NIH

Presentation transcript:

The Status and Future of Integrative and Organ Systems Sciences October 20 – 21, 2002 Bethesda, MD Sponsored by:APS and ASPET Co-sponsors: Burroughs Wellcome Fund Merck Research Laboratories Astra Zeneca

Life Sciences Research Office (LSRO) Michael Falk Executive Director

Mission To benefit society by evaluating biological information and scientific opinion for the public and private sectors

Steering Committee James R. Bloedel Joseph R. Haywood D. Euan MacIntyre Peter C. Preusch James H. Woods Edward J. Zambraski

Alternate Terms Integrative Systems Biology Organ Systems Translational Pre-clinical In vivo

Definitions Reductionist approaches are aimed at identifying molecular and cellular events, studied in purified form or in isolated systems and including genomics, proteomics, biochemistry and cell biology. Integrative and Organ Systems approaches are aimed at understanding how intact biological systems function at the level of whole animals, organs and organ systems (but not in the clinic).

Challenge Is this a real phenomenon or just perceptual? What data can we use to define the problem? Why is it happening? Can the causes by enumerated and assessed?